Benefit of Dietary Supplementation of Nutraceuticals as an Integrative Approach for Management of Migraine: Evidence From Preclinical and Clinical Studies
- PMID: 38430311
- PMCID: PMC12019864
- DOI: 10.1007/s11916-024-01230-w
Benefit of Dietary Supplementation of Nutraceuticals as an Integrative Approach for Management of Migraine: Evidence From Preclinical and Clinical Studies
Abstract
Purpose of review: To provide information from preclinical and clinical studies on the biological activity and health benefits of dietary inclusion of nutraceuticals as a safe, effective, non-pharmacological approach for the treatment of migraine.
Recent findings: There is emerging evidence of the therapeutic benefit of nutraceuticals to inhibit oxidative stress, suppress inflammation, and prevent changes in the normal gut microbiome, which are implicated in migraine pathology. Nutraceuticals can be enriched in polyphenols, which act as molecular scavengers to reduce the harmful effects of reactive oxygen species and phytosterols that suppress inflammation. Nutraceuticals also function to inhibit dysbiosis and to maintain the commensal intestinal bacteria that produce anti-inflammatory molecules including short-chain fatty acids that can act systemically to maintain a healthy nervous system. Dietary inclusion of nutraceuticals that exhibit antioxidant, anti-inflammatory, and anti-nociceptive properties and maintain the gut microbiota provides a complementary and integrative therapeutic strategy for migraine.
Keywords: Anti-inflammatory; Antioxidant; Gut microbiome; Migraine; Mineral; Nutraceutical.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Similar articles
-
Dietary Quercetin Supplementation Attenuates Diarrhea and Intestinal Damage by Regulating Gut Microbiota in Weanling Piglets.Oxid Med Cell Longev. 2021 Dec 13;2021:6221012. doi: 10.1155/2021/6221012. eCollection 2021. Oxid Med Cell Longev. 2021. Retraction in: Oxid Med Cell Longev. 2024 Jan 9;2024:9869280. doi: 10.1155/2024/9869280. PMID: 34950418 Free PMC article. Retracted.
-
The Gut Microbiome and Migraine: Updates in Understanding.Curr Neurol Neurosci Rep. 2025 Feb 22;25(1):20. doi: 10.1007/s11910-025-01408-8. Curr Neurol Neurosci Rep. 2025. PMID: 39985639 Review.
-
The Interaction Between Nutraceuticals and Gut Microbiota: a Novel Therapeutic Approach to Prevent and Treatment Parkinson's Disease.Mol Neurobiol. 2024 Nov;61(11):9078-9109. doi: 10.1007/s12035-024-04151-2. Epub 2024 Apr 8. Mol Neurobiol. 2024. PMID: 38587699 Review.
-
Nutraceuticals in migraine.Handb Clin Neurol. 2024;199:125-144. doi: 10.1016/B978-0-12-823357-3.00001-X. Handb Clin Neurol. 2024. PMID: 38307641 Review.
-
Usefulness of nutraceuticals in migraine prophylaxis.Neurol Sci. 2017 May;38(Suppl 1):117-120. doi: 10.1007/s10072-017-2901-1. Neurol Sci. 2017. PMID: 28527067 Review.
Cited by
-
Nutraceuticals: a promising, yet unregulated Frontier in Healthcare.Eur J Clin Nutr. 2025 May;79(5):413-418. doi: 10.1038/s41430-024-01557-y. Epub 2024 Dec 16. Eur J Clin Nutr. 2025. PMID: 39681616 Review.
-
Repeated Administrations of Polyphenolic Extracts Prevent Chronic Reflexive and Non-Reflexive Neuropathic Pain Responses by Modulating Gliosis and CCL2-CCR2/CX3CL1-CX3CR1 Signaling in Spinal Cord-Injured Female Mice.Int J Mol Sci. 2025 Apr 2;26(7):3325. doi: 10.3390/ijms26073325. Int J Mol Sci. 2025. PMID: 40244217 Free PMC article.
-
Fixed combination of palmitoylethanolamide and melatonin in preventive therapy of migraine: results from a randomized clinical trial.Front Nutr. 2025 Apr 10;12:1560654. doi: 10.3389/fnut.2025.1560654. eCollection 2025. Front Nutr. 2025. PMID: 40276532 Free PMC article.
-
Nutritional Strategies for Chronic Craniofacial Pain and Temporomandibular Disorders: Current Clinical and Preclinical Insights.Nutrients. 2024 Aug 27;16(17):2868. doi: 10.3390/nu16172868. Nutrients. 2024. PMID: 39275184 Free PMC article. Review.
-
The effects of concurrent alpha-linolenic acid, L-carnitine supplementation on clinical symptoms, mental health, and quality of life in women with migraine: a randomized, triple-blind, placebo-controlled trial.Nutr J. 2025 Mar 13;24(1):40. doi: 10.1186/s12937-025-01107-7. Nutr J. 2025. PMID: 40082970 Free PMC article. Clinical Trial.
References
-
- Steiner TJ, Stovner LJ. Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol. 2023;19(2):109–17. - PubMed
-
- Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. - PubMed
-
- Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631–49. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials